Adicet Bio ACET
NASDAQ ACET
$4.28 -0.21 (-4.68%)
At close: Oct 22, 2026 · 4:00 PM EDT

Adicet Bio (ACET) Non-Current Deffered Revenue (2019)

Updated

Adicet Bio's Non-Current Deffered Revenue came in at $10.89 million for Q4 2019.

Analysis

Adicet Bio (ACET) Non-Current Deffered Revenue (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Adicet Bio 40.07 Mn -477.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 10.89 Mn
API Access

Adicet Bio Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ACET&period=max&api_key=YOUR_API_KEY